Brief: 9 Meters Biopharma Inc - 9 Meters Biopharma Announces Phase 3 Study Of Vurolenatide In Short Bowel Syndrome

9 Meters Biopharma

29/11/2022 13:24

Nov 29 (Reuters) - 9 Meters Biopharma Inc  NMTR.O :
    * 9 METERS BIOPHARMA INC - 9 METERS BIOPHARMA ANNOUNCES
PHASE 3
STUDY OF VUROLENATIDE IN SHORT BOWEL SYNDROME
    * 9 METERS BIOPHARMA INC - STUDY DESIGN INCORPORATES TWO
PRIMARY
ENDPOINTS
    * 9 METERS BIOPHARMA - STUDY TO INCLUDE UP TO 50 SITES IN
NORTH
AMERICA AND EUROPE AND REMAINS ON TRACK WITH STUDY INITIATION AS
EARLY AS END-OF-YEAR

Further company coverage:  NMTR.O 
 ((Reuters.Briefs@thomsonreuters.com;;))